DK0757677T3 - Benzocyclohexylimidazolthionderivater - Google Patents

Benzocyclohexylimidazolthionderivater

Info

Publication number
DK0757677T3
DK0757677T3 DK95916449T DK95916449T DK0757677T3 DK 0757677 T3 DK0757677 T3 DK 0757677T3 DK 95916449 T DK95916449 T DK 95916449T DK 95916449 T DK95916449 T DK 95916449T DK 0757677 T3 DK0757677 T3 DK 0757677T3
Authority
DK
Denmark
Prior art keywords
thioxo
dihydro
benzocycloalkylazolethione
triazol
substituents
Prior art date
Application number
DK95916449T
Other languages
English (en)
Inventor
Gregory R Martinez
David B Repke
Philip J Teitelbaum
Keith A M Walker
Owen W Gooding
Roger L Whiting
Rekha P Bansal
Alexander V Muehldorf
Counde O'yang
Original Assignee
Roche Palo Alto Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27398461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0757677(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/233,655 external-priority patent/US5438150A/en
Priority claimed from US08/403,209 external-priority patent/US5538988A/en
Application filed by Roche Palo Alto Llc filed Critical Roche Palo Alto Llc
Application granted granted Critical
Publication of DK0757677T3 publication Critical patent/DK0757677T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Lubricants (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Polarising Elements (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Detergent Compositions (AREA)
  • Paints Or Removers (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DK95916449T 1994-04-26 1995-04-25 Benzocyclohexylimidazolthionderivater DK0757677T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23383594A 1994-04-26 1994-04-26
US08/233,655 US5438150A (en) 1994-04-26 1994-04-26 Process for making 1-benzocycloalkyl-1,3-dihydroimidazole-2-thione derivatives
US08/403,209 US5538988A (en) 1994-04-26 1995-03-17 Benzocycloalkylazolethione derivatives
PCT/US1995/004783 WO1995029165A2 (en) 1994-04-26 1995-04-25 Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors

Publications (1)

Publication Number Publication Date
DK0757677T3 true DK0757677T3 (da) 2003-10-13

Family

ID=27398461

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95916449T DK0757677T3 (da) 1994-04-26 1995-04-25 Benzocyclohexylimidazolthionderivater

Country Status (21)

Country Link
EP (1) EP0757677B1 (da)
JP (1) JPH09512269A (da)
CN (1) CN1113874C (da)
AT (1) ATE243199T1 (da)
AU (1) AU687192B2 (da)
BR (1) BR9507517A (da)
CA (1) CA2188748A1 (da)
CZ (1) CZ290082B6 (da)
DE (1) DE69531102T2 (da)
DK (1) DK0757677T3 (da)
ES (1) ES2201104T3 (da)
FI (1) FI964312A (da)
HU (1) HUT76295A (da)
IL (1) IL113480A (da)
MX (1) MX9605145A (da)
NO (1) NO311720B1 (da)
NZ (1) NZ284356A (da)
PL (1) PL185959B1 (da)
PT (1) PT757677E (da)
RU (1) RU2145321C1 (da)
WO (1) WO1995029165A2 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479484B1 (en) 1997-11-21 2002-11-12 Euro-Celtique S.A. Substituted 2-aminoacetamides and the use thereof
WO1999040063A1 (fr) * 1998-02-06 1999-08-12 Yoshitomi Pharmaceutical Industries, Ltd. Nouveaux derives de l'acide hydroxamique de type azapeptide
JP4978762B2 (ja) * 2001-03-30 2012-07-18 Ｄｉｃ株式会社 シクロヘキサ−３−エン−１−オール誘導体の製造方法
US7125904B2 (en) * 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
GB2393958A (en) * 2002-10-11 2004-04-14 Portela & Ca Sa Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase
GB0600709D0 (en) * 2006-01-13 2006-02-22 Portela & Ca Sa Drug combinations
AU2007331340A1 (en) 2006-12-12 2008-06-19 Bial-Portela & Ca, S.A. Catalytic process for asymmetric hydrogenation
EP2121668A2 (en) * 2007-02-01 2009-11-25 BIAL - Portela & Ca., S.A. 6,8-dichlorchroman-3-yl-1,3-dihydroimidazole-2-thione derivatives and their use for the treatment of cardiovascular disorders
EP1977646A1 (en) * 2007-04-03 2008-10-08 Bayer CropScience AG Insecticidal hydroxyethyl thlourea derivatives
GB0708818D0 (en) * 2007-05-08 2007-06-13 Portela & Ca Sa Compounds
GB0709695D0 (en) * 2007-05-21 2007-06-27 Portela & Ca Sa Process
TW200927740A (en) * 2007-11-13 2009-07-01 Bial Portela & Ca Sa Process
PT2726454T (pt) 2011-06-29 2018-05-07 Bial Portela & Ca Sa Processo
IN2015DN04089A (da) * 2012-11-14 2015-10-09 BIAL PORTELA & Cª S A
JP6843225B2 (ja) * 2016-07-28 2021-03-17 チャンスー ヤホン メディテック カンパニー リミテッド 癌の処置のためのドーパミンβ−ヒドロキシラーゼ（ＤＢＨ）阻害剤およびセロトニン受容体（５−ＨＴ）アンタゴニストの使用
JOP20190049A1 (ar) * 2016-09-23 2019-03-20 Bial Portela & C? S A مثبطات دوبامين-b-هيدروكسيلاز
CA3082337A1 (en) 2017-12-04 2019-06-13 Bial - Portela & Ca, S.A. Dopamine-b-hydroxylase inhibitors
GB201908044D0 (en) 2019-06-05 2019-07-17 Bial Portela & Ca Sa Dopamine-B-Hydroxylase inhibitors
KR20230137374A (ko) 2021-01-26 2023-10-04 장슈 야홍 메디텍 코퍼레이션 리미티드 경로 조절제, 이를 갖는 약학 조성물, 이의 용도 및 이를 이용한 치료 방법
CN113527108B (zh) * 2021-09-16 2022-10-25 斯芬克司药物研发（天津）股份有限公司 一种制备光学纯的5,7-二氟-1,2,3,4-四氢化萘-2-胺及其盐的方法
CN114920906B (zh) * 2022-05-23 2023-03-21 华南理工大学 一种含咪唑硫酮单元的聚氨酯及其制备方法和应用
WO2024056079A1 (zh) * 2022-09-16 2024-03-21 江苏亚虹医药科技股份有限公司 内匹司他酸加成盐的多晶型及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485917A (en) * 1966-04-14 1969-12-23 Janssen Pharmaceutica Nv Composition and method for combating fungus with imidazole carboxylates
GB8516573D0 (en) * 1985-07-01 1985-08-07 Janssen Pharmaceuticaa Nv Controlling weeds
EP0277384A3 (en) * 1986-12-24 1990-05-23 Janssen Pharmaceutica N.V. 1h-imidazole-5-carboxylic acid derivatives

Also Published As

Publication number Publication date
DE69531102T2 (de) 2004-04-29
NZ284356A (en) 1997-12-19
EP0757677A1 (en) 1997-02-12
RU2145321C1 (ru) 2000-02-10
EP0757677B1 (en) 2003-06-18
FI964312A0 (fi) 1996-10-25
DE69531102D1 (de) 2003-07-24
ES2201104T3 (es) 2004-03-16
CN1151735A (zh) 1997-06-11
CN1113874C (zh) 2003-07-09
NO964552D0 (no) 1996-10-25
PL316856A1 (en) 1997-02-17
JPH09512269A (ja) 1997-12-09
ATE243199T1 (de) 2003-07-15
AU687192B2 (en) 1998-02-19
HUT76295A (en) 1997-07-28
FI964312A (fi) 1996-12-20
WO1995029165A2 (en) 1995-11-02
NO311720B1 (no) 2002-01-14
IL113480A0 (en) 1995-07-31
PL185959B1 (pl) 2003-09-30
HU9602946D0 (en) 1996-12-30
NO964552L (no) 1996-12-27
AU2294795A (en) 1995-11-16
WO1995029165A3 (en) 1995-12-07
CZ290082B6 (cs) 2002-05-15
CA2188748A1 (en) 1995-11-02
PT757677E (pt) 2003-11-28
MX9605145A (es) 1997-12-31
IL113480A (en) 2000-06-29
BR9507517A (pt) 1997-09-16
CZ310996A3 (en) 1997-06-11

Similar Documents

Publication Publication Date Title
ATE243199T1 (de) Benzocyclohexylimidazolthion-derivate
DE69705829D1 (de) Meta-substituierte phenylsulphonamidderivate
DE69705300T2 (de) Cyclopropylalkansäurederivate
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
IL99759A (en) Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
DE69831868D1 (en) Antithrombosemittel
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
ES2164763T3 (es) Composiciones para el aclaramiento de la piel.
CA2221190A1 (en) Novel substituted taxanes and pharmaceutical compositions containing them
RS50035B (sr) Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje
BR9908545A (pt) Derivado de piperidina, processo para a preparação do mesmo, composto, processo para a preparação do mesmo, e, composição farmacêutica
CA2073686A1 (en) N,n'-dihaloimidazolidin-4-ones
ATE109787T1 (de) Latente alkylierungsubstituenten enthaltende anthracycline-analoge.
MX9805023A (es) Derivados de 1-metilcarbapenem.
UA27108A1 (uk) Аhтрацикліhові глікозиди та їх фармацевтичhо прийhятhі кислотhо-адитивhі солі, спосіб їх одержаhhя, похідhі 1,6-дийод-3-оксапеhтаhу та спосіб їх одержаhhя
EP0645382A4 (en) CUMARIN DERIVATIVES AND THEIR USE.
ES2182090T3 (es) Nuevos derivados de pirrol.
HU9503775D0 (en) Benzene derivative useful for ischemic diseases
AR004949A1 (es) Derivados de benzoil-4-pirazol, procedimiento para obtenerlos, composiciones herbicidas que los contienen y procedimientos para combatirplantas indeseables.
RU94044457A (ru) Применение бензтиофенов для ингибирования гирсутизма и алопеции у женщин
CA2052020A1 (en) Pradimicin derivatives
KR930703275A (ko) 벤조옥사디논유도체
NO20004685L (no) Nye forbindelser